XENT
Intersect ENT, Inc
XENT
XENT
Delisted
XENT was delisted on the 12th of May, 2022.
112 hedge funds and large institutions have $690M invested in Intersect ENT, Inc in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 53 increasing their positions, 36 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
62% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 34
Holders
112
Holding in Top 10
1
Calls
$15.1M
Puts
$4.13M
Top Buyers
| 1 | +$55.7M | |
| 2 | +$25.1M | |
| 3 | +$12.8M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$12.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$9.79M |
Top Sellers
| 1 | -$26M | |
| 2 | -$25.1M | |
| 3 | -$18.9M | |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$17M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.7M |